See rituximab on Wiktionary
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "",
"3": "-tu-",
"4": "-ximab",
"t2": "tumor",
"t3": "chimeric monoclonal antibody"
},
"expansion": "[Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”)",
"name": "af"
}
],
"etymology_text": "From [Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”).",
"forms": [
{
"form": "rituximabs",
"tags": [
"plural"
]
}
],
"head_templates": [
{
"args": {
"1": "-",
"2": "s"
},
"expansion": "rituximab (usually uncountable, plural rituximabs)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
{
"kind": "other",
"name": "English entries with incorrect language header",
"parents": [
"Entries with incorrect language header",
"Entry maintenance"
],
"source": "w"
},
{
"kind": "other",
"name": "English terms interfixed with -tu-",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "English terms suffixed with -ximab",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "Pages with 2 entries",
"parents": [],
"source": "w"
},
{
"kind": "topical",
"langcode": "en",
"name": "Pharmaceutical drugs",
"orig": "en:Pharmaceutical drugs",
"parents": [
"Drugs",
"Matter",
"Pharmacology",
"Chemistry",
"Nature",
"Biochemistry",
"Medicine",
"Sciences",
"All topics",
"Biology",
"Healthcare",
"Fundamental",
"Health",
"Body"
],
"source": "w"
}
],
"glosses": [
"A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis."
],
"id": "en-rituximab-en-noun-WNCEwzpt",
"links": [
[
"pharmacology",
"pharmacology"
],
[
"chimeric",
"chimeric"
],
[
"monoclonal antibody",
"monoclonal antibody"
],
[
"intravenous",
"intravenous"
],
[
"injection",
"injection"
],
[
"protein",
"protein"
],
[
"CD20",
"CD20"
],
[
"B cell",
"B cell"
],
[
"lysis",
"lysis"
]
],
"raw_glosses": [
"(pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis."
],
"synonyms": [
{
"word": "IDEC-C2B8"
}
],
"tags": [
"uncountable",
"usually"
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"rituximab"
]
}
],
"sounds": [
{
"ipa": "/ɹɪˈtʌk.sɪˌmæb/",
"tags": [
"General-American"
]
}
],
"word": "rituximab"
}
{
"forms": [
{
"form": "rituximabs",
"tags": [
"plural"
]
}
],
"head_templates": [
{
"args": {
"1": "f"
},
"expansion": "rituximab f (plural rituximabs)",
"name": "es-noun"
}
],
"hyphenation": [
"ri‧tu‧xi‧mab"
],
"lang": "Spanish",
"lang_code": "es",
"pos": "noun",
"senses": [
{
"categories": [
{
"kind": "other",
"name": "Pages with 2 entries",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "Spanish entries with incorrect language header",
"parents": [
"Entries with incorrect language header",
"Entry maintenance"
],
"source": "w"
},
{
"kind": "topical",
"langcode": "es",
"name": "Organic compounds",
"orig": "es:Organic compounds",
"parents": [
"Matter",
"Chemistry",
"Nature",
"Sciences",
"All topics",
"Fundamental"
],
"source": "w"
}
],
"glosses": [
"rituximab"
],
"id": "en-rituximab-es-noun-LknrPDT3",
"links": [
[
"organic chemistry",
"organic chemistry"
],
[
"rituximab",
"rituximab#English"
]
],
"raw_glosses": [
"(organic chemistry) rituximab"
],
"tags": [
"feminine"
],
"topics": [
"chemistry",
"natural-sciences",
"organic-chemistry",
"physical-sciences"
],
"wikipedia": [
"es:rituximab"
]
}
],
"sounds": [
{
"ipa": "/rituɡsiˈmab/"
},
{
"ipa": "[ri.t̪uɣ̞.siˈmaβ̞]"
},
{
"rhymes": "-ab"
}
],
"word": "rituximab"
}
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "",
"3": "-tu-",
"4": "-ximab",
"t2": "tumor",
"t3": "chimeric monoclonal antibody"
},
"expansion": "[Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”)",
"name": "af"
}
],
"etymology_text": "From [Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”).",
"forms": [
{
"form": "rituximabs",
"tags": [
"plural"
]
}
],
"head_templates": [
{
"args": {
"1": "-",
"2": "s"
},
"expansion": "rituximab (usually uncountable, plural rituximabs)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
"English countable nouns",
"English entries with incorrect language header",
"English lemmas",
"English nouns",
"English term requests",
"English terms interfixed with -tu-",
"English terms suffixed with -ximab",
"English uncountable nouns",
"Pages with 2 entries",
"en:Pharmaceutical drugs"
],
"glosses": [
"A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis."
],
"links": [
[
"pharmacology",
"pharmacology"
],
[
"chimeric",
"chimeric"
],
[
"monoclonal antibody",
"monoclonal antibody"
],
[
"intravenous",
"intravenous"
],
[
"injection",
"injection"
],
[
"protein",
"protein"
],
[
"CD20",
"CD20"
],
[
"B cell",
"B cell"
],
[
"lysis",
"lysis"
]
],
"raw_glosses": [
"(pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis."
],
"tags": [
"uncountable",
"usually"
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"rituximab"
]
}
],
"sounds": [
{
"ipa": "/ɹɪˈtʌk.sɪˌmæb/",
"tags": [
"General-American"
]
}
],
"synonyms": [
{
"word": "IDEC-C2B8"
}
],
"word": "rituximab"
}
{
"forms": [
{
"form": "rituximabs",
"tags": [
"plural"
]
}
],
"head_templates": [
{
"args": {
"1": "f"
},
"expansion": "rituximab f (plural rituximabs)",
"name": "es-noun"
}
],
"hyphenation": [
"ri‧tu‧xi‧mab"
],
"lang": "Spanish",
"lang_code": "es",
"pos": "noun",
"senses": [
{
"categories": [
"Pages with 2 entries",
"Rhymes:Spanish/ab",
"Rhymes:Spanish/ab/4 syllables",
"Spanish 4-syllable words",
"Spanish countable nouns",
"Spanish entries with incorrect language header",
"Spanish feminine nouns",
"Spanish lemmas",
"Spanish nouns",
"Spanish terms with IPA pronunciation",
"es:Organic compounds"
],
"glosses": [
"rituximab"
],
"links": [
[
"organic chemistry",
"organic chemistry"
],
[
"rituximab",
"rituximab#English"
]
],
"raw_glosses": [
"(organic chemistry) rituximab"
],
"tags": [
"feminine"
],
"topics": [
"chemistry",
"natural-sciences",
"organic-chemistry",
"physical-sciences"
],
"wikipedia": [
"es:rituximab"
]
}
],
"sounds": [
{
"ipa": "/rituɡsiˈmab/"
},
{
"ipa": "[ri.t̪uɣ̞.siˈmaβ̞]"
},
{
"rhymes": "-ab"
}
],
"word": "rituximab"
}
Download raw JSONL data for rituximab meaning in All languages combined (2.9kB)
This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-09-22 from the enwiktionary dump dated 2024-09-20 using wiktextract (af5c55c and 66545a6). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.
If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.